These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22640987)

  • 1. HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma.
    Kren L; Valkovsky I; Dolezel J; Capak I; Pacik D; Poprach A; Lakomy R; Redova M; Fabian P; Krenova Z; Slaby O
    Diagn Pathol; 2012 May; 7():58. PubMed ID: 22640987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response.
    Bukur J; Malenica B; Huber C; Seliger B
    Hum Immunol; 2003 Nov; 64(11):1081-92. PubMed ID: 14602239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
    Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
    Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
    Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
    Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, expression and function of HLA-G in renal cell carcinoma.
    Seliger B; Schlaf G
    Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.
    Sun D; Lu J; Ding K; Bi D; Niu Z; Cao Q; Zhang J; Ding S
    Med Oncol; 2013 Mar; 30(1):476. PubMed ID: 23371254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
    Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
    BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma.
    Li C; Li H; Zhang T; Li J; Ma F; Li M; Sui Z; Chang J
    Med Sci Monit; 2015 Nov; 21():3380-5. PubMed ID: 26540164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.
    Bukur J; Seliger B
    Semin Cancer Biol; 2003 Oct; 13(5):353-9. PubMed ID: 14708715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of endothelin 2 and localized clear cell renal cell carcinoma.
    Bot BM; Eckel-Passow JE; LeGrand SN; Hilton T; Cheville JC; Igel T; Parker AS
    Hum Pathol; 2012 Jun; 43(6):843-9. PubMed ID: 22047647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
    Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
    Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas.
    Yao M; Murakami T; Shioi K; Mizuno N; Ito H; Kondo K; Hasumi H; Sano F; Makiyama K; Nakaigawa N; Kishida T; Nagashima Y; Yamanaka S; Kubota Y
    Cancer Med; 2014 Aug; 3(4):845-54. PubMed ID: 24861371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).
    Baumunk D; Reichelt U; Hildebrandt J; Krause H; Ebbing J; Cash H; Miller K; Schostak M; Weikert S
    World J Urol; 2013 Oct; 31(5):1191-6. PubMed ID: 22544372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
    Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
    Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.
    Yan Y; Yang FQ; Zhang HM; Che J; Zheng JH
    Tumour Biol; 2014 Oct; 35(10):10479-86. PubMed ID: 25053596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E expression and its clinical relevance in human renal cell carcinoma.
    Seliger B; Jasinski-Bergner S; Quandt D; Stoehr C; Bukur J; Wach S; Legal W; Taubert H; Wullich B; Hartmann A
    Oncotarget; 2016 Oct; 7(41):67360-67372. PubMed ID: 27589686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.